137 related articles for article (PubMed ID: 38130958)
1. Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study.
Eerike M; Parimi VP; D M ; Pyati A; Sundaramurthy R; Sakthivadivel V; Pidugu AB; Pharm D ; Surapareddy B; Ramineni NT; Priyadarshini R; Patil PP
J Rheum Dis; 2024 Jan; 31(1):15-24. PubMed ID: 38130958
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.
Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D
Front Immunol; 2022; 13():846753. PubMed ID: 35309297
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis.
Nemeth D; Vago H; Tothfalusi L; Ulakcsai Z; Becker D; Szabo Z; Rojkovich B; Merkely B; Nagy G
Front Immunol; 2022; 13():960001. PubMed ID: 36311767
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
Saleem B; Ross RL; Bissell LA; Aslam A; Mankia K; Duquenne L; Corsadden D; Carter C; Hughes P; Nadat FA; Mulipa P; Lobb M; Clarke B; Mbara K; Morton R; Dibb S; Chowdhury R; Newton D; Pike A; Kakkar V; Savic S; DelGaldo F; Emery P
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35365569
[TBL] [Abstract][Full Text] [Related]
5. ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.
Picchianti-Diamanti A; Aiello A; Laganà B; Agrati C; Castilletti C; Meschi S; Farroni C; Lapa D; Najafi Fard S; Cuzzi G; Cimini E; Grassi G; Vanini V; Di Rosa R; Salemi S; Nalli G; Salmi A; Repele F; Altera AMG; Maffongelli G; Palazzolo C; Vita S; Leone S; Puro V; Capobianchi MR; Ippolito G; Nicastri E; Goletti D
Front Immunol; 2021; 12():740249. PubMed ID: 34594343
[TBL] [Abstract][Full Text] [Related]
6. Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19.
Eerike M; Sundaramurthy R; Gandham R; Sakthivadivel V; Amshala A; Priyadarshini R; Pyati AK; Patil P
Cureus; 2023 Apr; 15(4):e37316. PubMed ID: 37181975
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine.
Tedeschi SK; Solomon DH; Chen Y; Ellrodt J; Whelan MG; Stratton J; Hayashi K; Whiteman NB; Chen L; Adejoorin I; Marks KE; Gomez-Rivas E; Rao DA; Jonsson AH; Wesemann DR
Semin Arthritis Rheum; 2023 Apr; 59():152177. PubMed ID: 36796211
[TBL] [Abstract][Full Text] [Related]
8. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
Crnkic Kapetanovic M; Saxne T; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Jan; 15(1):R1. PubMed ID: 23286772
[TBL] [Abstract][Full Text] [Related]
9. The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis.
Roseman C; Truedsson L; Kapetanovic MC
Arthritis Res Ther; 2012 Jul; 14(4):R170. PubMed ID: 22824238
[TBL] [Abstract][Full Text] [Related]
10. Outcome of rheumatoid arthritis following adjunct statin therapy.
Das S; Mohanty M; Padhan P
Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine.
Dudley HM; O'Mara M; Auma A; Gong J; Ross Y; Gurevich N; Carbone S; Reihs A; Nguyen Y; McComsey GA; Cao Y; Balazs AB; Gordesky L; Payne M; Singer N; Kostadinova L; Wilson B; Zidar DA; King CL; Canaday DH; Shive CL; Mattar MM; Anthony DD
Vaccine; 2023 Sep; 41(41):6112-6119. PubMed ID: 37659895
[TBL] [Abstract][Full Text] [Related]
12. Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose.
Le Moine C; Soyfoo MS; Mekkaoui L; Dahma H; Tant L
Clin Exp Rheumatol; 2023 Jan; 41(1):82-87. PubMed ID: 35699073
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.
Zhao T; Shen J; Zhu Y; Tian X; Wen G; Wei Y; Xu B; Fu C; Xie Z; Xi Y; Li Z; Peng J; Wu Y; Tang X; Wan C; Pan L; Li Z; Qin D
Front Public Health; 2022; 10():875558. PubMed ID: 35548080
[TBL] [Abstract][Full Text] [Related]
14. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
Bae SC; Cho SK; Won S; Lee HS; Lee SH; Kang YM; Lee SH; Lee YA; Choe JY; Chung WT; Suh CH; Shim SC; Lee J; Yoon BY; Kim DW; Lee SS; Yoo WH; Kim JS; Jung YO; Nah SS; Lee CK; Song GG; Choi SJ; Joung CI; Koh H; Kim YJ
Int J Rheum Dis; 2018 May; 21(5):1001-1009. PubMed ID: 29878615
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum C-C chemokine ligand 19 levels in patients with rheumatoid arthritis].
Shi LJ; Li JH; Hu FL; Li M; Zhang J; Li JT; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):667-671. PubMed ID: 29263510
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
Arvikar SL; Collier DS; Fisher MC; Unizony S; Cohen GL; McHugh G; Kawai T; Strle K; Steere AC
Arthritis Res Ther; 2013; 15(5):R109. PubMed ID: 24017968
[TBL] [Abstract][Full Text] [Related]
18. Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination.
Whelan MG; Santacroce L; Masto L; Qian G; Kowalski E; Vanni K; Kanjilal S; Weinblatt ME; Sparks JA; Tedeschi SK
Clin Rheumatol; 2023 Jun; 42(6):1695-1700. PubMed ID: 36656454
[TBL] [Abstract][Full Text] [Related]
19. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA).
Frodlund M; Nived P; Chatzidionysiou A; Södergren A; Klingberg E; Bengtsson A; Hansson M; Olsson S; Pin E; Klareskog L; Kapetanovic MC
Vaccine; 2023 May; 41(20):3247-3257. PubMed ID: 37076360
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Int J Rheum Dis; 2018 Nov; 21(11):1977-1985. PubMed ID: 27452347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
